{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:36Z","timestamp":1792090476913,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:00:00Z","timestamp":1602374400000},"content-version":"vor","delay-in-days":1532,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1074\/jbc.r116.714576","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T17:30:24Z","timestamp":1466530224000},"page":"16485-16493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["Cross-interactions between the Alzheimer Disease Amyloid-\u03b2 Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis"],"prefix":"10.1016","volume":"291","author":[{"given":"Jinghui","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian K.T.S.","family":"W\u00e4rml\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Gr\u00e4slund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Pieter","family":"Abrahams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.R116.714576_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/cn300050d","article-title":"Familial Alzheimer's disease mutations differentially alter amyloid \u03b2-protein oligomerization","volume":"3","author":"Gessel","year":"2012","journal-title":"ACS Chem. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Short communication Lewy bodies contain altered \u03b1-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.R116.714576_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11357-015-9747-3","article-title":"Amyloid and tau pathology of familial Alzheimer's disease APP\/PS1 mouse model in a senescence phenotype background","volume":"37","author":"Porquet","year":"2015","journal-title":"Age (Dordr.)"},{"key":"10.1074\/jbc.R116.714576_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JAD-2009-0960","article-title":"Accumulated amyloid-\u03b2 peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease","volume":"16","author":"Huang","year":"2009","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00775-014-1131-8","article-title":"The hairpin conformation of the amyloid \u03b2 peptide is an important structural motif along the aggregation pathway","volume":"19","author":"Abelein","year":"2014","journal-title":"JBIC J. Biol. Inorg. Chem"},{"key":"10.1074\/jbc.R116.714576_bib6","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1021\/bi5003579","article-title":"Alzheimer peptides aggregate into transient nanoglobules that nucleate fibrils","volume":"53","author":"Luo","year":"2014","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.R116.714576_bib7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and \u201cwingmen.\u201d","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib9","doi-asserted-by":"crossref","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","article-title":"Proteolytic degradation of amyloid \u03b2-protein","volume":"2","author":"Saido","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1074\/jbc.R116.714576_bib10","doi-asserted-by":"crossref","first-page":"15095","DOI":"10.1074\/jbc.M110.199356","article-title":"Amyloid-\u03b242 interacts mainly with insoluble prion protein in the Alzheimer brain","volume":"286","author":"Zou","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib11","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.1074\/jbc.M112.400358","article-title":"Prion protein-mediated toxicity of amyloid-\u03b2 oligomers requires lipid rafts and the transmembrane LRP1","volume":"288","author":"Rushworth","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib12","doi-asserted-by":"crossref","first-page":"33104","DOI":"10.1074\/jbc.C112.400614","article-title":"Soluble prion protein inhibits amyloid-\u03b2 (A\u03b2) fibrillization and toxicity","volume":"287","author":"Nieznanski","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib13","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","article-title":"An N-terminal fragment of the prion protein binds to amyloid-\u03b2 oligomers and inhibits their neurotoxicity in vivo","volume":"288","author":"Fluharty","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib14","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/ncomms3416","article-title":"Amyloid-\u03b2 nanotubes are associated with prion protein-dependent synaptotoxicity","volume":"4","author":"Nicoll","year":"2013","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.R116.714576_bib15","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/cbic.201300262","article-title":"Biophysical studies of the amyloid \u03b2-peptide: Interactions with metal ions and small molecules","volume":"14","author":"W\u00e4rml\u00e4nder","year":"2013","journal-title":"Chembiochem"},{"key":"10.1074\/jbc.R116.714576_bib16","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1523\/JNEUROSCI.5924-09.2010","article-title":"Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases","volume":"30","author":"Morales","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"key":"10.1074\/jbc.R116.714576_bib18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3233\/JAD-2010-101071","article-title":"Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease","volume":"22","author":"Whitehouse","year":"2010","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib19","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between A\u03b2, tau, and \u03b1-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using \u03b1-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"key":"10.1074\/jbc.R116.714576_bib21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","article-title":"Interaction between A\u03b2 peptide and \u03b1 synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease","volume":"31","author":"Mandal","year":"2006","journal-title":"Neurochem. Res"},{"key":"10.1074\/jbc.R116.714576_bib22","doi-asserted-by":"crossref","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases","volume":"3","author":"Tsigelny","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.R116.714576_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1471-4159.2012.07847.x","article-title":"Cross-seeding effects of amyloid \u03b2-protein and \u03b1-synuclein","volume":"122","author":"Ono","year":"2012","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.R116.714576_bib24","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","article-title":"\u03b2-Amyloid peptides enhance \u03b1-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease","volume":"98","author":"Masliah","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.R116.714576_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.40.1.1","article-title":"The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity","volume":"40","author":"Hansen","year":"1990","journal-title":"Neurology"},{"key":"10.1074\/jbc.R116.714576_bib26","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of \u03b1-synuclein and A\u03b2 in Parkinson disease patients with dementia","volume":"69","author":"Kotzbauer","year":"2012","journal-title":"Arch. Neurol"},{"key":"10.1074\/jbc.R116.714576_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1074\/jbc.R116.714576_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau: a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1073\/pnas.0509386103","article-title":"A\u03b2 and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease","volume":"103","author":"Guo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.R116.714576_bib30","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","article-title":"A\u03b2 oligomers cause localized Ca2+ elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines","volume":"30","author":"Zempel","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2353\/ajpath.2008.070904","article-title":"Amyloid activates GSK-3\u03b2 to aggravate neuronal tauopathy in bigenic mice","volume":"172","author":"Terwel","year":"2008","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.R116.714576_bib32","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1074\/jbc.R116.714576_bib33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.mp.4001508","article-title":"Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy","volume":"9","author":"G\u00f6tz","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.R116.714576_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/B:MCBI.0000049373.15558.b8","article-title":"Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone","volume":"267","author":"Santhoshkumar","year":"2004","journal-title":"Mol. Cell Biochem"},{"key":"10.1074\/jbc.R116.714576_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nbd.2015.08.024","article-title":"Protective properties of lysozyme on \u03b2-amyloid pathology: implications for Alzheimer disease","volume":"83","author":"Helmfors","year":"2015","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.R116.714576_bib36","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1039\/c3cc42325e","article-title":"Human lysozyme inhibits the in vitro aggregation of A\u03b2 peptides, which in vivo are associated with Alzheimer's disease","volume":"49","author":"Luo","year":"2013","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1074\/jbc.R116.714576_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer's disease?","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1074\/jbc.R116.714576_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3 a regulates production of Alzheimer's disease amyloid-\u03b2 peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"10.1074\/jbc.R116.714576_bib39","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of \u03b2-amyloid precursor protein trafficking by insulin reduces intraneuronal \u03b2-amyloid and requires mitogen-activated protein kinase signaling","volume":"21","author":"Gasparini","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-\u03b2 peptide in Alzheimer's disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.R116.714576_bib41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/mol.107.036913","article-title":"Insulin facilitates the hepatic clearance of plasma amyloid \u03b2-peptide (1\u201340) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes","volume":"72","author":"Tamaki","year":"2007","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.R116.714576_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid \u03b2 oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J"},{"key":"10.1074\/jbc.R116.714576_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/acschemneuro.5b00325","article-title":"Reciprocal molecular interactions between the A\u03b2 peptide linked to Alzheimer's disease and insulin linked to diabetes mellitus type II","volume":"7","author":"Luo","year":"2016","journal-title":"ACS Chem. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","article-title":"Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology","volume":"1537","author":"Jaikaran","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.R116.714576_bib45","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1074\/jbc.275.19.14077","article-title":"Alzheimer's \u03b2-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line","volume":"275","author":"Kawahara","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib46","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.febslet.2013.01.046","article-title":"Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity","volume":"587","author":"Cao","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.R116.714576_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1567205043480555","article-title":"The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease","volume":"1","author":"Nicolls","year":"2004","journal-title":"Curr. Alzheimer Res"},{"key":"10.1074\/jbc.R116.714576_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JAD-131238","article-title":"Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits","volume":"39","author":"Mehla","year":"2014","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib49","doi-asserted-by":"crossref","first-page":"17490","DOI":"10.1074\/jbc.M311300200","article-title":"Seeding specificity in amyloid growth induced by heterologous fibrils","volume":"279","author":"O'Nuallain","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib50","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/anie.200604056","article-title":"IAPP mimic blocks A\u03b2 cytotoxic self-assembly: cross-suppression of amyloid toxicity of A\u03b2 and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes","volume":"46","author":"Yan","year":"2007","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"10.1074\/jbc.R116.714576_bib51","doi-asserted-by":"crossref","first-page":"10378","DOI":"10.1002\/anie.201302840","article-title":"Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and A\u03b240","volume":"52","author":"Yan","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"10.1074\/jbc.R116.714576_bib52","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/anie.200904902","article-title":"Identification of hot regions of the A\u03b2-IAPP interaction interface as high-affinity binding sites in both cross- and self-association","volume":"49","author":"Andreetto","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"10.1074\/jbc.R116.714576_bib53","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nchem.1433","article-title":"Amyloid \u03b2-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity","volume":"4","author":"Cheng","year":"2012","journal-title":"Nat. Chem"},{"key":"10.1074\/jbc.R116.714576_bib54","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1074\/jbc.R116.714576_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1750-1326-6-79","article-title":"Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?","volume":"6","author":"Li","year":"2011","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.R116.714576_bib56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nlm.2007.07.006","article-title":"Transthyretin influences spatial reference memory","volume":"88","author":"Sousa","year":"2007","journal-title":"Neurobiol. Learn. Mem"},{"key":"10.1074\/jbc.R116.714576_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/JAD-131355","article-title":"Transthyretin stabilization by iododiflunisal promotes amyloid-\u03b2 peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model","volume":"39","author":"Ribeiro","year":"2014","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib58","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1006\/bbrc.1999.0552","article-title":"High levels of circulating A\u03b242 are sequestered by plasma proteins in Alzheimer's disease","volume":"257","author":"Kuo","year":"1999","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.R116.714576_bib59","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.febslet.2008.02.034","article-title":"Transthyretin binding to A-\u03b2 peptide: impact on A-\u03b2 fibrillogenesis and toxicity","volume":"582","author":"Costa","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.R116.714576_bib60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/protein\/gzs026","article-title":"Identification of \u03b2-amyloid-binding sites on transthyretin","volume":"25","author":"Du","year":"2012","journal-title":"Protein Eng. Des. Sel"},{"key":"10.1074\/jbc.R116.714576_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13506120600960288","article-title":"Structure, function and amyloidogenic propensity of apolipoprotein A-I","volume":"13","author":"Obici","year":"2006","journal-title":"Amyloid"},{"key":"10.1074\/jbc.R116.714576_bib62","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1021\/bi002186k","article-title":"Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A \u03b2 aggregation and toxicity","volume":"40","author":"Koldamova","year":"2001","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.R116.714576_bib63","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ana.20593","article-title":"APOA1 polymorphism influences risk for early-onset nonfamiliar AD","volume":"58","author":"Vollbach","year":"2005","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.R116.714576_bib64","doi-asserted-by":"crossref","first-page":"36958","DOI":"10.1074\/jbc.M110.127829","article-title":"Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease","volume":"285","author":"Lewis","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0305-0491(96)00025-9","article-title":"Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution","volume":"114","author":"H\u00e5kansson","year":"1996","journal-title":"Comp. Biochem. Physiol. B. Biochem. Mol. Biol"},{"key":"10.1074\/jbc.R116.714576_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fnmol.2012.00079","article-title":"Cystatin C in Alzheimer's disease","volume":"5","author":"Kaur","year":"2012","journal-title":"Front. Mol. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/00365510601009738","article-title":"Cystatin C reduces the in vitro formation of soluble A\u03b21\u201342 oligomers and protofibrils","volume":"67","author":"Selenica","year":"2007","journal-title":"Scand. J. Clin. Lab. Invest"},{"key":"10.1074\/jbc.R116.714576_bib68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JAD-2010-1291","article-title":"Cystatin C protects neuronal cells from amyloid-\u03b2-induced toxicity","volume":"19","author":"Tizon","year":"2010","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib69","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.neurobiolaging.2003.11.006","article-title":"Binding of cystatin C to Alzheimer's amyloid \u03b2 inhibits in vitro amyloid fibril formation","volume":"25","author":"Sastre","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.R116.714576_bib70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3233\/JAD-2009-1147","article-title":"Complexes of amyloid-\u03b2 and cystatin C in the human central nervous system","volume":"18","author":"Mi","year":"2009","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib71","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2008.10.001","article-title":"Cystatin C-cathepsin B axis regulates amyloid \u03b2 levels and associated neuronal deficits in an animal model of Alzheimer's disease","volume":"60","author":"Sun","year":"2008","journal-title":"Neuron"},{"key":"10.1074\/jbc.R116.714576_bib72","doi-asserted-by":"crossref","first-page":"39834","DOI":"10.1074\/jbc.M112.371641","article-title":"Cathepsin B degrades amyloid-\u03b2 in mice expressing wild-type human amyloid precursor protein","volume":"287","author":"Wang","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib73","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3233\/JAD-2012-120076","article-title":"Serum amyloid P component accelerates the formation and enhances the stability of amyloid fibrils in a physiologically significant under-saturated solution of amyloid-\u03b242","volume":"29","author":"Mold","year":"2012","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib74","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/13506129709003838","article-title":"Amyloid P component: a critical review","volume":"4","author":"Pepys","year":"1997","journal-title":"Amyloid"},{"key":"10.1074\/jbc.R116.714576_bib75","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"},{"key":"10.1074\/jbc.R116.714576_bib76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3233\/JAD-2012-120820","article-title":"Fibrinogen and altered hemostasis in Alzheimer's disease","volume":"32","author":"Cortes-Canteli","year":"2012","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib77","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2353\/ajpath.2007.060664","article-title":"Evidence of a role for lactadherin in Alzheimer's disease","volume":"170","author":"Boddaert","year":"2007","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.R116.714576_bib78","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1471-4159.2012.07845.x","article-title":"Huntingtin associated protein 1 regulates trafficking of the amyloid precursor protein and modulates amyloid \u03b2 levels in neurons","volume":"122","author":"Yang","year":"2012","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.R116.714576_bib79","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3233\/JAD-2010-100717","article-title":"Deficiency of the copper chaperone for superoxide dismutase increases amyloid-\u03b2 production","volume":"21","author":"Gray","year":"2010","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.R116.714576_bib80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0197-0186(03)00101-3","article-title":"Overexpression of superoxide dismutase 1 protects against \u03b2-amyloid peptide toxicity: effect of estrogen and copper chelators","volume":"44","author":"Celsi","year":"2004","journal-title":"Neurochem. Int"},{"key":"10.1074\/jbc.R116.714576_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2016.03.009","article-title":"Characterization of Mn(II) ion binding to the amyloid-\u03b2 peptide in Alzheimer's disease","author":"Wallin","year":"2016","journal-title":"J. Trace Elem. Med. Biol"},{"key":"10.1074\/jbc.R116.714576_bib82","doi-asserted-by":"crossref","first-page":"e59005","DOI":"10.1371\/journal.pone.0059005","article-title":"Cu2+ affects amyloid-\u03b2(1\u201342) aggregation by increasing peptide-peptide binding forces","volume":"8","author":"Hane","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.R116.714576_bib83","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1021\/bm401874j","article-title":"Endogenous polyamines reduce the toxicity of soluble A\u03b2 peptide aggregates associated with Alzheimer's disease","volume":"15","author":"Luo","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1074\/jbc.R116.714576_bib84","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/cn300170x","article-title":"Cellular polyamines promote amyloid-\u03b2 (a\u03b2) Peptide fibrillation and modulate the aggregation pathways","volume":"4","author":"Luo","year":"2013","journal-title":"ACS Chem. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib85","doi-asserted-by":"crossref","first-page":"27766","DOI":"10.1074\/jbc.M114.574947","article-title":"Non-chaperone proteins can inhibit aggregation and cytotoxicity of Alzheimer amyloid \u03b2 peptide","volume":"289","author":"Luo","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.R116.714576_bib86","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jmr.699","article-title":"The effect of macromolecular crowding on protein aggregation and amyloid fibril formation","volume":"17","author":"Munishkina","year":"2004","journal-title":"J. Mol. Recognit"},{"key":"10.1074\/jbc.R116.714576_bib87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-biochem-060208-092442","article-title":"Molecular chaperone functions in protein folding and proteostasis","volume":"82","author":"Kim","year":"2013","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.R116.714576_bib88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2004.09.075","article-title":"Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers","volume":"577","author":"Sparr","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.R116.714576_bib89","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease: amyloid pores from pathogenic mutations","volume":"418","author":"Lashuel","year":"2002","journal-title":"Nature"},{"key":"10.1074\/jbc.R116.714576_bib90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrneurol.2013.275","article-title":"Extracellular \u03b1-synuclein: a novel and crucial factor in Lewy body diseases","volume":"10","author":"Lee","year":"2014","journal-title":"Nat. Rev. Neurol"},{"key":"10.1074\/jbc.R116.714576_bib91","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mcn.2014.06.012","article-title":"Molecular and cellular neuroscience intracellular \u03b1-synuclein affects early maturation of primary oligodendrocyte progenitor cells","volume":"62","author":"Ettle","year":"2014","journal-title":"Mol. Cell Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib92","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1074\/jbc.R116.714576_bib93","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio.1002","article-title":"Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria","volume":"8","author":"Adler-Abramovich","year":"2012","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.R116.714576_bib94","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1039\/C4NR00291A","article-title":"The A\u03b2 peptide forms non-amyloid fibrils in the presence of carbon nanotubes","volume":"6","author":"Luo","year":"2014","journal-title":"Nanoscale"},{"key":"10.1074\/jbc.R116.714576_bib95","doi-asserted-by":"crossref","first-page":"21812","DOI":"10.1073\/pnas.1010373107","article-title":"Alzheimer's disease peptide \u03b2-amyloid interacts with fibrinogen and induces its oligomerization","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.R116.714576_bib96","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.R116.714576_bib97","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"\u03b2-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy","volume":"4","author":"Soto","year":"1998","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.R116.714576_bib98","doi-asserted-by":"crossref","first-page":"17338","DOI":"10.1002\/chem.201301535","article-title":"Inhibiting and reversing amyloid-\u03b2 peptide (1\u201340) fibril formation with gramicidin S and engineered analogues","volume":"19","author":"Luo","year":"2013","journal-title":"Chemistry"},{"key":"10.1074\/jbc.R116.714576_bib99","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/chem.201304253","article-title":"Cyclic peptides as inhibitors of amyloid fibrillation","volume":"20","author":"Luo","year":"2014","journal-title":"Chemistry"},{"key":"10.1074\/jbc.R116.714576_bib100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature.2015.18031","article-title":"Alzheimer's drugs show progress","volume":"523","author":"Reardon","year":"2015","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1074\/jbc.a116.714576","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000}}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820353734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820353734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.R116.714576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:57:06Z","timestamp":1641279426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820353734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":100,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0021925820353734"],"URL":"https:\/\/doi.org\/10.1074\/jbc.r116.714576","relation":{"correction":[{"id-type":"doi","id":"10.1074\/jbc.A116.714576","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-interactions between the Alzheimer Disease Amyloid-\u03b2 Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.R116.714576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}